EcoDrugPlus

Estrogen Receptor Beta-Like

Ensembl ID : ENSLBEG00000016458
Gene Symbol: LOC109988416
3 Cross references
198 Possible Orthologues:

Estrogen Receptor Beta-Like

Ensembl ID : ENSLBEG00000028922
Gene Symbol: LOC109979724
3 Cross references
207 Possible Orthologues:

Estrogen Receptor Beta-Like

Ensembl ID : ENSLBEG00000003119
Gene Symbol: LOC109977616
3 Cross references
207 Possible Orthologues:

Estrogen Receptor-Like

Ensembl ID : ENSLBEG00000016616
Gene Symbol: LOC109983285
3 Cross references
215 Possible Orthologues:

Estrogen-Related Receptor Gamma A

Ensembl ID : ENSLBEG00000004785
Gene Symbol: ESRRGA
1 Cross references
198 Possible Orthologues:

Exportin 1

Ensembl ID : ENSLBEG00000005740
Gene Symbol: XPO1
3 Cross references
211 Possible Orthologues:

Exportin 1

Ensembl ID : ENSLBEG00000002104
Gene Symbol: XPO1
3 Cross references
223 Possible Orthologues:

Farnesyl Diphosphate Synthase

Ensembl ID : ENSLBEG00000026711
Gene Symbol: FDPS
3 Cross references
266 Possible Orthologues:

Farnesyl Pyrophosphate Synthase-Like

Ensembl ID : ENSLBEG00000010647
Gene Symbol: LOC109980473
3 Cross references
266 Possible Orthologues:

Farnesyl-Diphosphate Farnesyltransferase 1

Ensembl ID : ENSLBEG00000011877
Gene Symbol: FDFT1
3 Cross references
220 Possible Orthologues:

Farnesyltransferase, Caax Box, Alpha

Ensembl ID : ENSLBEG00000013995
Gene Symbol: FNTA
3 Cross references
221 Possible Orthologues:

Fibroblast Growth Factor Receptor 1-A-Like

Ensembl ID : ENSLBEG00000007287
Gene Symbol: LOC109982009
4 Cross references
209 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).